Different effects of newly isolated saponins on the mutagenicity and cytotoxicity of the anticancer drugs mitomycin C and bleomycin in human lymphocytes

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 420, Issue 1-3, 1998, Pages 49-54

  Scarpato, R ^a   Bertoli, A ^a   Naccarati, A ^a   Migliore, L ^a   Cocchi, L ^a   Barale, R ^a   Pistelli, L ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Antimutagenicity; Bleomycin; Human lymphocyte; Micronucleus; Mitomycin C

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; MITOMYCIN C; SAPONIN;

ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; GENOTOXICITY; HUMAN; HUMAN CELL; LYMPHOCYTE; MICRONUCLEUS TEST; MUTAGENICITY; PRIORITY JOURNAL;

ANTIMETABOLITES, ANTINEOPLASTIC; BLEOMYCIN; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LYMPHOCYTES; MALE; MICRONUCLEUS TESTS; MITOMYCIN; MUTAGENS; NUCLEIC ACID SYNTHESIS INHIBITORS; PLANTS; SAPONINS;

BUPLEURUM FRUTICOSUM;

EID: 0032420224     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5718(98)00146-6     Document Type: Article

References (32)

1. Ferguson L.R., Pearson A. The clinical use of mutagenic anticancer drug. Mutat. Res. 355:1996;1-12.
2. Ames B.N. Dietary carcinogens. Science. 221:1983;1256-1263.
3. Gebhart E., Wagner H., Grzivok K., Behensen H. The action of anticlastogens in human lymphocyte cultures and their modification by rat liver S9 mix: II. Studies with vitamins C and E. Mutat. Res. 149:1985;83-94.
4. Sasaki Y.F., Imanishi H., Ohta T., Shirasu Y. Modifying effects of components of plant essence on the induction of sister-chromatid exchanges in cultured Chinese hamster ovary cells. Mutat. Res. 226:1989;103-110.
5. Kojima H., Konishi H., Kuroda Y. Effects of L-ascorbic acid on the mutagenicity of ethyl methanesulfonate in cultured mammalian cells. Mutat. Res. 266:1992;85-91.
6. Vijayalaxmi, Reiter R.J., Meltz M.L. Melatonin protects human blood lymphocytes from radiation-induced chromosome damage. Mutat. Res. 346:1995;23-31.
7. Okai Y., Higashi-Okai K., Nakamura S., Yano Y., Otani S. Suppressive effects of retinoids, carotenoids and antioxidant vitamins on heterocyclic amine-induce umu C gene expression in Salmonella typhimurium (TA 1535/pSK 1002). Mutat. Res. 368:1996;133-140.
8. RoyChoudhury A., Das T., Sharma A., Talukder G. Dietary garlic extract in modifying clastogenic effects of inorganic arsenic in mice: two-generation studies. Mutat. Res. 359:1996;165-170.
9. Yen G.C., Chen H.Y. Relationship between antimutagenic activity an major components of various teas. Mutagenesis. 11:1996;37-41.
10. Gonzales de Mejia E., Ramos-Gomez M., Loarca-Piña G. Antimutagenic activity of natural xantophylls against aflatoxin B1 in Salmonella typhimurium. Environ. Mol. Mutagen. 30:1997;346-353.
11. Tang X., Edenharder R. Inhibition of the mutagenicity of 2-nitrofluorene, 3-nitrofluoranthene and 1-nitro pyrene by vitamins, porphyrins and relate compounds and vegetable an fruit juices and solvent extracts. Food Chem. Toxicol. 35:1997;373-378.
12. Quetin-Leclercq J., Elias R., Balansard G., Bassleer R., Angenot L. Cytotoxic activity of some triterpenoid saponins. Planta Medica. 58:1992;279-281.
13. Hasegawa H., Matsumiya S., Uchiyama M., Kurokawa H., Inoye Y., Kasai R., Ishibashi S., Yamasaki K. Inhibitory effect of some triterpenoid saponins on glucose transport in tumor cells and its application to in vitro cytotoxic and antiviral activities. Planta Medica. 60:1993;241-243.
14. Yen M.H., Lin C.C., Yen C.M. The immunomodulatory effect of saikosaponin derivatives and the root extract of Blupeurum kaoi in mice. Phytother. Res. 9:1995;351-358.
15. Scarpato R., Pistelli L., Bertoli A., Nieri E., Migliore L. In vitro genotoxicity and cytotoxicity of five new chemical compounds of plant origin by means of the human lymphocyte micronucleus assay. Toxicol. Vitro. 12:1998;153-161.
16. Pistelli L., Bilia A.R., Marsili A., De Tommasi N., Manunta A. Triterpenoid saponins from Bupleurum fruticosum. J. Nat. Prod. 56:1993;240-243.
17. Scarpato R., Migliore L., Angotzi G., Fedi A., Miligi L., Loprieno N. Cytogenetic monitoring of a group of Italian floriculturists: no evidence of DNA damage related to pesticide exposure. Mutat. Res. 367:1996;73-82.
18. Elias R., De Méo M., Vidal-Ollivier E., Laget M., Balansard G., Duménil G. Antimutagenic activity of some saponins isolated from Calendula officinalis L., C. arvensis L. and Hedera helix L. Mutagenesis. 5:1990;321-327.
19. Aït Amara-Mokrane Y., Lehucher-Michel M.P., Balansard G., Duménil G., Botta A. Protective effects of α-hederin, chlorophyllin and ascorbic acid towards the induction of micronuclei by doxorubicin in cultured human lymphocytes. Mutagenesis. 11:1996;161-167.
20. Romert L., Curvall M., Jenssen D. Chlorophyllin is both a positive and negative modifier of mutagenicity. Mutagenesis. 7:1992;349-355.
21. Sanayal R., Darrouddi F., Parzefall W., Nagao M., Knasmller S. Inhibition of the genotoxic effects of heterocyclic amines in human derived hepatoma cells by dietary bioantimutagens. Mutagenesis. 12:1997;297-303.
22. Ferguson L.R., Denny W.A. Anticancer drugs: an underestimated risk or an underutilised resource in mutagenesis? Mutat. Res. 331:1995;1-26.
23. Povirk L.F. DNA damage an mutagenesis by radiomimetic DNA-cleaving agents: bleomycin, neocarzinostatin and other enedynes. Mutat. Res. 355:1996;71S-89S.
24. Danloy J., Quetin-Leclercq F.C., De Pauw-Gillet M.C., Elias R., Balansard G., Angenot L., Bassleer R. Effect of α-hederin, a saponin extracted from Hedera helix, on cells cultured in vitro. Planta Medica. 60:1993;45-49.
25. Yamashita N., Murata M., Inoue S., Hiraku Y., Yoshinaga T., Kawanishi S. Superoxide formation and DNA damage induce by a fragrant furanone in the presence of copper(II). Mutat. Res. 397:1998;191-201.
26. Chernomorsky S., Rancourt R., Virdi K., Segelman A., Poretz R.D. Antimutagenicity, cytotoxicity and composition of chlorophyllin copper complex. Cancer Lett. 120:1997;141-147.
27. Odin A.P. Antimutagenicity of the porphyrins and non-enzyme porphyrin-containing proteins. Mutat. Res. 387:1997;55-68.
28. Dashwood R.H. Protection by chlorophyllin against the covalent binding of 2-amino-3-methylimidazo-4,5-f-quinolone (IQ) to the rat liver DNA. Carcinogenesis. 13:1992;113-118.
29. Arimoto S., Fukuoka S., Itome C., Nakano H., Rai H., Hayatsu H. Binding of polycyclic planar mutagens to chlorophyllin resulting in inhibition of the mutagenic activity. Mutat. Res. 287:1993;293-305.
30. Hayatsu H., Negishi T., Arimoto S., Hayatsu T. Porphyrins as potential inhibitors against exposure to carcinogens and mutagens. Mutat. Res. 290:1993;79-85.
31. Morales-Ramirez P., Garcia-Rodriguez M.C. In vivo effect of chlorophyllin on γ-ray-induced sister chromatid exchange in murine bone marrow cells. Mutat. Res. 320:1994;329-334.
32. Nelson R.L. Chlorophyllin, an antimutagen, acts as a tumor promoter in the rat-dimethylhydrazine colon carcinogenesis model. Anticancer Res. 12:1992;737-740.